Molecular Targeted Therapy Market Size, Share, Growth, and Industry Analysis, By Types (Monoclonal Antibodies, Small Molecule Inhibitors), By Applications Covered (Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Others), Regional Insights and Forecast to 2033

Detailed TOC of Global Molecular Targeted Therapy Market Research Report 2025

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Targeted Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Monoclonal Antibodies
1.2.3 Small Molecule Inhibitors
1.3 Market by Application
1.3.1 Global Molecular Targeted Therapy Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Lung Cancer
1.3.3 Breast Cancer
1.3.4 Colorectal Cancer
1.3.5 Leukemia
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Targeted Therapy Market Perspective (2018-2033)
2.2 Molecular Targeted Therapy Growth Trends by Region
2.2.1 Global Molecular Targeted Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Molecular Targeted Therapy Historic Market Size by Region (2018-2025)
2.2.3 Molecular Targeted Therapy Forecasted Market Size by Region (2024-2033)
2.3 Molecular Targeted Therapy Market Dynamics
2.3.1 Molecular Targeted Therapy Industry Trends
2.3.2 Molecular Targeted Therapy Market Drivers
2.3.3 Molecular Targeted Therapy Market Challenges
2.3.4 Molecular Targeted Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Targeted Therapy Players by Revenue
3.1.1 Global Top Molecular Targeted Therapy Players by Revenue (2018-2025)
3.1.2 Global Molecular Targeted Therapy Revenue Market Share by Players (2018-2025)
3.2 Global Molecular Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Targeted Therapy Revenue
3.4 Global Molecular Targeted Therapy Market Concentration Ratio
3.4.1 Global Molecular Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Targeted Therapy Revenue in 2022
3.5 Molecular Targeted Therapy Key Players Head office and Area Served
3.6 Key Players Molecular Targeted Therapy Product Solution and Service
3.7 Date of Enter into Molecular Targeted Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Targeted Therapy Breakdown Data by Type
4.1 Global Molecular Targeted Therapy Historic Market Size by Type (2018-2025)
4.2 Global Molecular Targeted Therapy Forecasted Market Size by Type (2024-2033)
5 Molecular Targeted Therapy Breakdown Data by Application
5.1 Global Molecular Targeted Therapy Historic Market Size by Application (2018-2025)
5.2 Global Molecular Targeted Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Molecular Targeted Therapy Market Size (2018-2033)
6.2 North America Molecular Targeted Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Molecular Targeted Therapy Market Size by Country (2018-2025)
6.4 North America Molecular Targeted Therapy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Targeted Therapy Market Size (2018-2033)
7.2 Europe Molecular Targeted Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Molecular Targeted Therapy Market Size by Country (2018-2025)
7.4 Europe Molecular Targeted Therapy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Targeted Therapy Market Size (2018-2033)
8.2 Asia-Pacific Molecular Targeted Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Molecular Targeted Therapy Market Size by Region (2018-2025)
8.4 Asia-Pacific Molecular Targeted Therapy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Targeted Therapy Market Size (2018-2033)
9.2 Latin America Molecular Targeted Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Molecular Targeted Therapy Market Size by Country (2018-2025)
9.4 Latin America Molecular Targeted Therapy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Targeted Therapy Market Size (2018-2033)
10.2 Middle East & Africa Molecular Targeted Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Molecular Targeted Therapy Market Size by Country (2018-2025)
10.4 Middle East & Africa Molecular Targeted Therapy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Phoenix Molecular Designs
11.1.1 Phoenix Molecular Designs Company Detail
11.1.2 Phoenix Molecular Designs Business Overview
11.1.3 Phoenix Molecular Designs Molecular Targeted Therapy Introduction
11.1.4 Phoenix Molecular Designs Revenue in Molecular Targeted Therapy Business (2018-2025)
11.1.5 Phoenix Molecular Designs Recent Development
11.2 Prelude Therapeutics
11.2.1 Prelude Therapeutics Company Detail
11.2.2 Prelude Therapeutics Business Overview
11.2.3 Prelude Therapeutics Molecular Targeted Therapy Introduction
11.2.4 Prelude Therapeutics Revenue in Molecular Targeted Therapy Business (2018-2025)
11.2.5 Prelude Therapeutics Recent Development
11.3 Tempus
11.3.1 Tempus Company Detail
11.3.2 Tempus Business Overview
11.3.3 Tempus Molecular Targeted Therapy Introduction
11.3.4 Tempus Revenue in Molecular Targeted Therapy Business (2018-2025)
11.3.5 Tempus Recent Development
11.4 Bracco
11.4.1 Bracco Company Detail
11.4.2 Bracco Business Overview
11.4.3 Bracco Molecular Targeted Therapy Introduction
11.4.4 Bracco Revenue in Molecular Targeted Therapy Business (2018-2025)
11.4.5 Bracco Recent Development
11.5 iOmx Therapeutics
11.5.1 iOmx Therapeutics Company Detail
11.5.2 iOmx Therapeutics Business Overview
11.5.3 iOmx Therapeutics Molecular Targeted Therapy Introduction
11.5.4 iOmx Therapeutics Revenue in Molecular Targeted Therapy Business (2018-2025)
11.5.5 iOmx Therapeutics Recent Development
11.6 OncoDNA
11.6.1 OncoDNA Company Detail
11.6.2 OncoDNA Business Overview
11.6.3 OncoDNA Molecular Targeted Therapy Introduction
11.6.4 OncoDNA Revenue in Molecular Targeted Therapy Business (2018-2025)
11.6.5 OncoDNA Recent Development
11.7 Sapience Therapeutics
11.7.1 Sapience Therapeutics Company Detail
11.7.2 Sapience Therapeutics Business Overview
11.7.3 Sapience Therapeutics Molecular Targeted Therapy Introduction
11.7.4 Sapience Therapeutics Revenue in Molecular Targeted Therapy Business (2018-2025)
11.7.5 Sapience Therapeutics Recent Development
11.8 Caris Life Sciences
11.8.1 Caris Life Sciences Company Detail
11.8.2 Caris Life Sciences Business Overview
11.8.3 Caris Life Sciences Molecular Targeted Therapy Introduction
11.8.4 Caris Life Sciences Revenue in Molecular Targeted Therapy Business (2018-2025)
11.8.5 Caris Life Sciences Recent Development
11.9 Hera Biolabs
11.9.1 Hera Biolabs Company Detail
11.9.2 Hera Biolabs Business Overview
11.9.3 Hera Biolabs Molecular Targeted Therapy Introduction
11.9.4 Hera Biolabs Revenue in Molecular Targeted Therapy Business (2018-2025)
11.9.5 Hera Biolabs Recent Development
11.10 CV6 Therapeutics
11.10.1 CV6 Therapeutics Company Detail
11.10.2 CV6 Therapeutics Business Overview
11.10.3 CV6 Therapeutics Molecular Targeted Therapy Introduction
11.10.4 CV6 Therapeutics Revenue in Molecular Targeted Therapy Business (2018-2025)
11.10.5 CV6 Therapeutics Recent Development
11.11 Carrick Therapeutics
11.11.1 Carrick Therapeutics Company Detail
11.11.2 Carrick Therapeutics Business Overview
11.11.3 Carrick Therapeutics Molecular Targeted Therapy Introduction
11.11.4 Carrick Therapeutics Revenue in Molecular Targeted Therapy Business (2018-2025)
11.11.5 Carrick Therapeutics Recent Development
11.12 Foundation Medicine
11.12.1 Foundation Medicine Company Detail
11.12.2 Foundation Medicine Business Overview
11.12.3 Foundation Medicine Molecular Targeted Therapy Introduction
11.12.4 Foundation Medicine Revenue in Molecular Targeted Therapy Business (2018-2025)
11.12.5 Foundation Medicine Recent Development
11.13 Cybrexa Therapeutics
11.13.1 Cybrexa Therapeutics Company Detail
11.13.2 Cybrexa Therapeutics Business Overview
11.13.3 Cybrexa Therapeutics Molecular Targeted Therapy Introduction
11.13.4 Cybrexa Therapeutics Revenue in Molecular Targeted Therapy Business (2018-2025)
11.13.5 Cybrexa Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details